This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.
Company Filing History:
1 out of 834,411 Years Active: 2013
Title: Moutih Rafei: Innovator in Therapeutic Conjugates
Introduction
Moutih Rafei is a notable inventor based in Pierrefonds, Canada. He has made significant contributions to the field of therapeutic proteins, particularly through his innovative work on conjugate proteins. His research focuses on the intersection of immunology and therapeutic applications, showcasing his expertise in this vital area of science.
Latest Patents
Moutih Rafei holds a patent for "GM-CSF and truncated CCL2 conjugates and methods and uses thereof." This patent describes a conjugate protein that comprises GM-CSF or a fragment thereof and a truncated CCL2. The conjugate protein exhibits unexpected immune suppressive, anti-obesity, and tumoricidal properties, making it useful in a variety of therapeutic applications. He has 1 patent to his name, reflecting his innovative contributions to the field.
Career Highlights
Throughout his career, Moutih Rafei has focused on developing novel therapeutic strategies that leverage the unique properties of conjugate proteins. His work has the potential to impact various medical fields, including oncology and metabolic disorders. His research is characterized by a commitment to advancing scientific knowledge and improving patient outcomes.
Collaborations
Moutih Rafei collaborates with Jacques Galipeau, a fellow researcher in the field. Their partnership exemplifies the collaborative spirit of scientific research, where shared expertise can lead to groundbreaking discoveries.
Conclusion
Moutih Rafei's innovative work in the development of therapeutic conjugates highlights his role as a significant contributor to the field of immunology. His patent on GM-CSF and truncated CCL2 conjugates showcases the potential for new therapeutic applications that could benefit many patients.